AGoogle DeepMind just dropped a model that could change how we find disease genes.
BAnother AI breakthrough. What does this one actually do?
AIt's called AlphaGenome 2. It predicts how DNA variants affect specific cell types.
BSo instead of just finding a mutation, it tells you where that mutation actually matters.
AExactly. And it finds nearly twice as many disease-linked variants as the last version.
BTwice as many. That's not incremental. That's a real jump.
AThe Polymarket account posted it as breaking news. The replies went straight to lupus and APS.
BPeople want cures. And this model can help researchers zero in on the right immune cells.
ABut here's the catch: it's research only. Not for clinical diagnosis.
BSo no doctor is using this tomorrow. But the drug discovery pipeline just got a lot faster.
AAnd that's where the money is. Faster target identification means cheaper trials.
BIf this works, biotech valuations are going to get very interesting.
ASpeaking of chips and money—there's an unverified report about Nvidia's H200 chips ending up at a Chinese university on a US export blacklist.
BShocking. Export controls working perfectly, I see.
AUnusual Whales posted that a Chinese university with PLA ties bought them last month, despite being blacklisted.
BAnd Reuters is supposedly the source. But I haven't seen the actual Reuters piece yet.
ARight. The claim is out there, but no official confirmation. The rumor mill is running hot.
BIf it's true, someone in the supply chain is making a killing. These chips are supposedly gold on the black market.
AAnd it would mean the export controls have real holes. Big ones.
BThe controls were always going to leak. The question is how fast and how much.
AMeanwhile, the Nasdaq is ripping. One account says it's up two percent.
BTech is back, if that account is right. AI stocks recovering after that inflation scare.
ABut here's the thing—some traders are now pricing in a rate HIKE in December.
BA hike? After all this talk of cuts? That's a massive reversal.
AOne post claims a fourteen percent chance of a fifty basis point hike. Fourteen percent!
BThat's not nothing. The Fed was supposed to be easing. Now they might tighten?
AThe CPI data came in hotter than expected. Headline up point four percent month over month.
BAnd core up point three. Inflation is sticky. That's the problem.
ASo the market is doing this weird dance—stocks up, but rate hike odds also up.
BBecause AI earnings are strong, the story goes, but the Fed might have to fight inflation harder.
AIt's a tug of war. And right now, both sides are winning.
BThat can't last. One of these has to give.
AAnd then there's Adam Neumann. Litquidity says he dropped an absolute banger on the timeline.
BThe WeWork guy? What's he posting now?
ANo idea what the post actually says, and I'm not sure Litquidity does either.
BNeumann's timeline is always a trip. The man has made a career out of big swings, and still posts like a guru.
AHe's got a new venture now. Flow. Trying to do real estate again.
BOf course he is. You can't keep a guy like that down. The ego is the business model.
AAnd Trump is posting about Iran. 'We won in Iran,' he says.
BWon what? There's no context. Just the claim.
ANo official word yet on what he's referring to. The account just posted the quote.
BThat's the thing with these breaking accounts. They give you the headline, not the story.
AIf there's a real development in Iran, the market will care. Oil prices, defense stocks.
BBut right now it's just a quote. I'll wait for the details before I care.
AAnd on Bluesky, the health care fight is heating up. The Tennessee Holler is quoting Buffett.
BThe tapeworm line. He's used it for years. Health care costs eating the economy alive.
AThey're pushing Medicare for All. Single payer. The whole system.
BAnd that's the answer? Just have the government run everything?
ATheir argument is that private insurance is the tapeworm. Cut it out.
BBut the government doesn't exactly have a great track record on efficiency either.
ABuffett's point was about competitiveness. American companies pay more for health care than foreign rivals.
BThat's true. But the fix isn't automatically single payer. There are other ways to cut costs.
ALike what? More competition? Transparency?
BExactly. Let people see prices. Let insurers compete across state lines. Actually fix the market.
ABut the Holler's point is that the market has failed. Decades of rising premiums.
BThe market hasn't failed. It's been strangled by regulation and hidden prices.
AWe're not solving health care in the next two minutes. But the fight is real.
BAnd it's only going to get louder as costs keep climbing.
AOne more from Bluesky—Mike Drucker with a jab at the whole economy.
BHe says things are so fragile that one CEO missing an obvious honeypot trap could collapse everything.
AThat's the state of things. One guy, one bad click, and we're all in trouble.
BIt's a joke, but it's not entirely wrong. Concentration risk is real.
AWhen a handful of companies drive the whole market, one mistake echoes everywhere.
BAnd that's the world we're living in. Big tech, big AI, big everything.
AAlright, that's the picture at midday. AI breakthroughs, chip leaks, rate hike whispers, and a health care fight.
BNever a dull moment. We'll be back with more after this.